#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

    Recruiting

    2 1 1 1
    Investigated drugs:
    Belgium Denmark France Greece Italy The Netherlands +2

  • Study on the Safety and Effects of EIK1004 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Denmark France Portugal Spain

  • Study on Indocyanine Green with Extracellular Vesicles for Better Tumor Visualization in Patients Undergoing Surgery for Digestive System Cancers

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Managing Rheumatological Side Effects in Cancer Patients Using Fludeoxyglucose (18F) and Checkpoint Inhibitors

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Safety and Effects of MK-3120 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Investigated drugs:
    France The Netherlands Poland Spain

  • Study on the Safety and Effectiveness of ATTR-01 for Adults with Certain Types of Solid Tumors

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain

  • Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

    Recruiting

    2 1 1 1
    Investigated drugs:
    France Italy Spain

  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Denmark France Germany Hungary Italy +3